Posted On: 04/19/2014 1:35:10 PM
Post# of 273345
Agilent Technologies (A) 54.65 $A
Even With A Change At The Top, Danaher Corporation Will Roll On
Stephen D., Simpson,, The Motley Fool - Motley Fool - Thu Apr 17, 5:30PM CDT
Multi-industry conglomerate Danaher definitely buried the lede this quarter, as news of the unexpected retirement of well-liked CEO H. Lawrence Culp next year overshadowed an otherwise "OK ... but not great" quarter. Losing a good CEO is also a...
Danaher CEO Change, Guidance Underwhelm Investors
at Investor's Business Daily - Thu Apr 17, 11:31AM CDT
Scientific instrument maker Danaher (DHR) was down 1.5% in heavy volume in morning trading on the stock market today after it announced a new CEO and guided Q2 a bit below consensus. Late Wednesday, Danaher released Q1 earnings and announced that CEO...
Agilent Technologies Thought Leader Award Supports Dr. Joshua Rabinowitz's Research at Princeton University
Business Wire - Thu Apr 17, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) today announced that Joshua Rabinowitz, M.D., Ph.D., professor at Princeton University's Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics, has received an Agilent Thought Leader Award to support his work on quantitative analysis of cellular metabolism.
TRADE NEWS: Agilent Technologies Announces Certification of HDMI 2.0 Test Solution for HDMI 2.0 Compliance Test, With Widest Coverage of Test Items
Business Wire - Thu Apr 17, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) today announced that the Agilent HDMI 2.0 test solution has been certified by the HDMI Forum as an official compliance test tool. The solution has the widest coverage for HDMI Physical layer compliance test. Certification was achieved with the collaborative framework of Panasonic; the solution will be used at the Panasonic Authorized Test Center, in Osaka, Japan.
Global Liquid Chromatography Systems Market 2014-2018 with Agilent, GE, Shimadzu, Thermo Fisher Scientific & Waters Dominating
M2 - Thu Apr 17, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3svgnk/global_liquid) has announced the addition of the "Global Liquid Chromatography Systems Market 2014-2018" report to their offering. The Global Liquid Chromatography Systems market to grow at a CAGR of 5.55 percent over the period 2013-2018. One of the major trends witnessed in the market is the increased outsourcing of drug manufacturing to the APAC region. Many global pharmaceutical companies are facing challenges such as patent expirations and pricing pressures. As a result, these companies are on the lookout for cost-containment measures. For instance, drug manufacturing in the APAC countries is less expensive than in western countries. Therefore, western nations are increasingly outsourcing all the stages of the manufacturing process, including the purification of biopharmaceutical and other biochemical entities, to the CROs and CMOs located in the APAC region to achieve cost-efficiency. As a result, the APAC region is emerging as the fastest growing market and many multinational companies and local companies have set up their operations in this region to provide automated liquid chromatography systems to CROs and CMOs. Therefore, the continuous outsourcing of pharmaceutical production to the APAC region is expected to drive the growth of the Global Liquid Chromatography Systems market. According to the report, one of the major drivers in this market is the increasing automation of liquid chromatography systems. The usage of automated liquid chromatography instruments with auto-samplers to process large number of samples and the usage of analyzers with customized system settings have gained popularity recently. Further, the report states that one of the major challenges in this market is the requirement for high purification standards. To maintain the efficiency of liquid chromatography instruments, vendors are forced to build standards to deliver the highest quality systems. Moreover, the complex nature of biochemical entities poses a challenge for vendors to develop and maintain the instrument standards for purification. Liquid chromatography systems include: - HPLC - UHPLC - Others types of liquid chromatography systems Key Vendors - Agilent Technologies Inc. - GE Healthcare - Shimadzu Corp. - Thermo Fisher Scientific Inc. - Waters Corp. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product Type - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/3s...bal_liquid
TRADE NEWS: Agilent Technologies Announces Availability of Reference Solutions That Speed Test-System Development
Business Wire - Wed Apr 16, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) today announced the availability of Reference Solutions, a combination of hardware, software and measurement expertise that delivers the essential components of electronic test systems.
Research and Markets: Global Companion Diagnostics Market 2014-2018 with Abbott Laboratories, Agilent Technologies, bioMrieux SA, Qiagen N.V. & Roche Holding Dominating
Business Wire - Wed Apr 16, 6:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/84cgmr/global_companion) has announced the addition of the "Global Companion Diagnostics Market 2014-2018" report to their offering.
Global Companion Diagnostics Market 2014-2018 with Abbott Laboratories, Agilent Technologies, bioMerieux SA, Qiagen N.V. & Roche Holding Dominating
M2 - Wed Apr 16, 5:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3lb2g2/global_companion) has announced the addition of the "Global Companion Diagnostics Market 2014-2018" report to their offering. The Global Companion Diagnostics market will grow at a CAGR of 18.59 percent over the period 2013-2018. One of the major trends being witnessed in the market is the increase in growth strategies among vendors. Many diagnostic companies are adopting various strategies such as licensing agreements, product launches, collaborations, acquisitions, capital investment, and government support to develop companion diagnostic theranostic tests and targeted therapeutics and to strengthen their diagnostics product portfolio. Thus, many such activities are expected to boost the development of new diagnostic devices, thereby bolstering the growth of the Global Companion Diagnostics market during the forecast period. According to the report, the increased focus on cost cutting in the drug discovery and development process is one of the major drivers. The growth of genomics and proteomics has enabled the understanding of different expression stages associated with a specific disease among the human population. This has enabled many companies to develop highly specific drugs known as targeted therapeutics. It has also allowed better management of the drug development process, resulting in effective cost management. The paradigm shift in the focus to develop targeted therapeutics has enabled the development of companion diagnostic tests to monitor and administer patients with ease. Further, the report states that one of the major challenges in this market is the high cost involved in the development of companion diagnostics. The cost of developing companion diagnostics is high and adds to the overall cost of the targeted therapeutics and diagnostic tests. This report covers the present scenario and the growth prospects of the Global Companion Diagnostics market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of companion diagnostic tests and associated kits provided by the vendors. It also presents the vendor landscape and a corresponding detailed analysis of key five vendors in the Global Companion Diagnostics market. The market is highly fragmented, with the presence of many small and large vendors. It includes vendors that operate across the globe and have a substantial presence in North America and the European Union. In addition, the report discusses the major drivers that influence the growth of the Global Companion Diagnostics market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market. Key Vendors - Abbott Laboratories - Agilent Technologies Inc. - bioM?rieux SA - Qiagen N.V. - Roche Holding AG Other Prominent Vendors - 20/20 Genesystems Inc. - A & G Pharmaceutical Inc. - AccuTheranostics Inc. - Alacris Theranostics GmbH - AutoGenomics Inc. - Biogenex Laboratories Inc. - Leica Biosystems GmbH - Life Technologies Inc. - Luminex Corp. - pHLOGISTIX LLC - Spartan Bioscience Inc. - TheraDiag S.A. - Theranostics Health Inc. - Ventana Medical Systems Inc. Key Market Drivers/Trends/Challenges - Increasing Focus on Reducing the Cost of Drug Discovery and Development. - High Cost Associated with the Development of Companion Diagnostics. - Increase in Growth Strategies among Vendors Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/3l..._companion
Coverage of Health Care Sector Stocks -- Research on Agilent Technologies, Thermo Fisher Scientific, Nordion, and BG Medicine
PR Newswire - Tue Apr 15, 10:08AM CDT
On Monday, April 14, 2014, the NASDAQ Composite ended at 4,022.69, up 0.57%, the Dow Jones Industrial Average advanced 0.91% to 16,173.24, and the S&P 500 closed at 1,830.61, up 0.82%. The gains were broad based as all the 10 sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has declined 3.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), Nordion Inc. (NYSE: NDZ) and BG Medicine Inc. (NASDAQ: BGMD). Free technical research on A, TMO, NDZ and BGMD can be downloaded upon signing up at:
TRADE NEWS: Agilent Technologies Offers First User-Extensible Recorder Application for Real-Time Spectrum Analyzers
Business Wire - Tue Apr 15, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) today announced the availability of the option RTR, the industry's first real-time spectrum recorder and analyzer application example for real-time spectrum analyzers (RTSAs).
Xilinx's DDR4 Memory Solution for UltraScale Devices Completes Agilent N6462A Compliance Test Running at 2400 Mb/s
PR Newswire - Mon Apr 14, 6:00AM CDT
Xilinx, Inc. (NASDAQ: XLNX) and Agilent Technologies Inc. (NYSE:A) today announced Xilinx's DDR4 memory solution for UltraScale(TM) devices has completed the Agilent N6462A compliance test running at 2400 Mb/s. As defined by the JEDEC JESD79-4 DDR4 DRAM specification, the Agilent N6462A DDR4 compliance test enables early adopters of DDR4 technology to make critical electrical and timing analysis for characterization and margin testing purposes. The DDR4 memory interface in the Xilinx® UltraScale(TM) All Programmable FPGAs provides more than 1 Tb/s of memory bandwidth to handle the massive data flow, fast processing, and enormous memory requirements of leading-edge, next-generation system designs in key applications such as video imaging and processing, traffic management, and high-performance computing.
Global Molecular Spectroscopy (NMR, UV-Visible, IR, NIR, Raman) Market 2014-2018
M2 - Fri Apr 11, 9:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5g3ztn/molecular) has announced the addition of the "Global Molecular Spectroscopy (NMR, UV-Visible, IR, NIR, Raman) Market 2014-2018" report to their offering. Owing to the diverse nature of molecular spectroscopy technologies, these technologies cover a wide area of applications. The wide application of NMR spectroscopy, improvements in Raman technologies, and miniaturization of molecular spectroscopy instruments are the factors that are contributing to the growth of the market. The demand for molecular spectroscopy systems is growing, owing to the increasing requirements in the life sciences and pharmaceutical industries as wells as the substantial demand from the chemical and petrochemical industries. Moreover, the growing market for terahertz technology has resulted in the rapid growth of the market. The key factors propelling the growth of this market are increased investments, funding, and grants by government bodies worldwide; ongoing new product launches; technological advancements; increase in the number of conferences, which helps to create awareness about molecular spectroscopy techniques; growing concerns over food and drug safety; and increasing use of molecular spectroscopy techniques in the fields of proteomics, biomarkers, and metabolomics. This report broadly categorizes the global market into different technologies and applications. Based on products, the market comprises NMR Spectroscopy, Ultraviolet-Visible Spectroscopy (UV-Vis), Infrared Spectroscopy (IR), Near Infrared (NIR) Spectroscopy, Color Measurement Spectroscopy, Raman Spectroscopy, and others. The NMR Spectroscopy segment includes Continuous Wave NMR spectroscopy, Fourier Transform NMR spectroscopy, Solid-State NMR spectroscopy, and others. The Ultraviolet-Visible Spectroscopy (UV-Vis) segment comprises Single-beam UV-vis spectroscopy, Dual-beam UV-vis spectroscopy, Array-based UV-vis spectroscopy, handheld UV-vis spectroscopy, and others. The Infrared Spectroscopy (IR) market is further segment into market by spectrum and market by technology. The IR market by spectrum includes short-wave Infrared spectroscopy, mid-wave Infrared spectroscopy, and far-wave Infrared spectroscopy. The IR market by technology includes markets for benchtop, hyphenated, microscopy, portable, and terahertz spectroscopy. The Raman spectroscopy market is segmented by sampling technique and by technology. NMR spectroscopy accounted for the largest share of the overall molecular spectroscopymetry market, by technology, followed by UV-VIS spectroscopy. However, the Raman spectroscopy segment is expected to grow at the highest CAGR from 2013 to 2018. This high growth can be attributed to its technological advancements, and growing adoption in the pharmaceutical industry. Based on applications, the market is segmented into pharmaceuticals, biotechnology & biopharmaceuticals, food & beverage testing, environmental testing, academic research institutes, and others. Based on geography, the market is divided into North America, Europe, Asia, and the Rest of World (RoW). North America is the largest market for molecular spectroscopy, followed by Europe and Asia. However, the Asian market is slated to grow at the highest rate over the next five years. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 By Technology 5 By Application 6 By Geography 7 Competitive Landscape 8 Company Profiles - Agilent Technologies, Inc. - Bruker - Danaher Corporation - Foss - Jasco, Inc. - Jeol Ltd. - Perkinelmer, Inc. - Shimadzu Corporation - The Abb Group - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/5g3ztn/molecular
5 Stocks to Sell Before It's Too Late
at The Street - Fri Apr 11, 7:38AM CDT
It's time to unload these toxic stocks from your portfolio.
Global High Throughput Screening (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics) Market 2014-2018
M2 - Fri Apr 11, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnx4xn/high_throughput) has announced the addition of the "High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018" report to their offering. The global HTS market was valued at $13,736 million in 2013 and is expected to reach $19,627 million by 2018, at a CAGR of 7.4% In recent years, the high throughput screening (HTS) market has witnessed a large number of technological advancements, which has resulted in an increase in the rate of adoption of HTS in laboratories. . The HTS market is broadly classified into five segments, namely, technologies, products, applications, end users, and geography. The technology market is sub-divided into ultra high throughput screening, cell-based assays, lab-on-a chip, label-free technology, and bioinformatics. The cell-based assays segment dominated the HTS market in 2013, followed by the lab-on-a-chip segment. The HTS products market is broadly categorized into instruments, consumables/reagents, and software and services. The consumables/reagents segment dominated this market in 2013, with a market share of around 57%. The applications market is segmented into target identification, primary screening, toxicology, stem cell biology, and others. Target identification dominated the HTS applications market in 2013, followed by the primary screening market. The HTS market by end user is broadly categorized into pharmaceutical companies, biotechnology companies, academic and government institutes, contract research organizations (CROs), and others. The pharmaceuticals segment dominated the market in 2013, with a market share of around 48%. The major factors driving the growth of the HTS market are technological innovations, open innovation models adopted by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in HTS technology by organizations. Moreover, the presence of a large untapped market in emerging countries and growth in outsourcing of drug discovery services especially in China and India are the various factors that are expected to provide growth opportunities for players in this market. However, the capital intensive nature of HTS and difficulties in assay development for novel target classes are the factors curbing the growth of this market. Company Profiles - Agilent Technologies, Inc. - Aurora Biomed - Axxam Spa - Beckman Coulter, Inc. (A Subsidiary Of Danaher) - Bio-Rad Laboratories - Biofocus Dpi Ltd. - Intellicyt Corporation - Luminex Corporation - Perkinelmer, Inc. - Sigma Aldrich Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. Scope of the Report Technology - Cell-Based Assay - Ultra high throughput screening (uHTS)Lab-on-a-chip - Label Free Technology - Bioinformatics Product - Instruments - Consumables/Reagents - Software and Services Application - Target Identification - Primary Screening - Toxicology - Stem Cell Biology - Others End User - Pharmaceutical - Biotechnology - Academic & Government Organizations - Contract Research Organizations - Others For more information visit http://www.researchandmarkets.com/research/wn...throughput
African Electronic Test Equipment Market Report 2014 - Telecoms & Education Present Significant Opportunities in the Next 5-7 Years
M2 - Wed Apr 09, 10:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j8npbx/african) has announced the addition of the "African Electronic Test Equipment Market" report to their offering. Africa is an emerging market for vendors of electronic test equipment. Its telecommunications and education sectors present significant opportunities in the next 5 to 7 years. This research service analyzes the market for the major types of electronic test equipment, including oscilloscopes, spectrum analyzers, network analyzers, signal generators, multimeters, power meters, electronic counters, logic analyzers, and arbitrary waveform generators. Featuring revenue forecast for the total market as well as each product segment, it analyzes the market from an end-user and geographic perspective. A detailed market share analysis by revenue of the leading participants is also supplied at the regional level. Key Topics Covered: - Introduction - Executive Summary - Market Overview - Total Market - CEO 360 degree Perspective - Oscilloscopes Segment Breakdown - Spectrum Analyzers Segment Breakdown - Network Analyzers Segment Breakdown - Multimeters Segment Breakdown - Signal Generators Segment Breakdown - Power Meters Segment Breakdown - Electronic Counters Segment Breakdown - Logic Analyzers Segment Breakdown - AWG Segment Breakdown - North Africa Breakdown - Sub-Saharan Africa Breakdown - The Last Word - Appendix Companies Mentioned - Aeroflex - Agilent Technologies - Anritsu - Boonton Electronics - Comtest - Concilium Technologies - Extech - Fluke - Good Will Instruments - Hameg - LeCroy - Major Tech - RIGOL - Rohde & Schwarz - Tektronix - Yokogawa For more information visit http://www.researchandmarkets.com/research/j8npbx/african
Agilent names Paul Clark and James Cullen as directors on Keysight Technologies' board
M2 - Wed Apr 09, 9:42AM CDT
Agilent Technologies Inc (NYSE:A), a measurement and technology company, revealed on Tuesday that it will appoint Paul N Clark and James G Cullen to Keysight Technologies Inc's board of directors and Clark will become the chairman of the board.
Global In-Vitro Toxicology/Toxicity Testing (Cell Culture, HTS, Omics) Market 2014-2018
M2 - Wed Apr 09, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/59cs9d/invitro) has announced the addition of the "In-Vitro Toxicology/ Toxicity Testing Market by Industry, Technology, Applications & Method - Global Forecast to 2018" report to their offering. The global market of in-vitro toxicology testing is subdivided into industry, technology, method, application and geography. On the basis of industry, the market is further segmented into diagnostics, pharmaceuticals, chemicals, cosmetics, and food. Diagnostics is further categorized into sample and type. The largest market share was captured by the pharmaceutical industry, whereas cosmetics industry was the fastest growing industry with a double digit CAGR. The prime factor contributing to the growth of pharmaceutical industry has been the attention towards the detection of toxicity during earlier stages of development. On the basis of technology, the global market of in vitro toxicology testing is divided into cell culture, high throughput screening, cellular imaging, and omics technologies. Cell culture technology will witness the maximum growth rate in the coming years. The methods considered for the study are cellular assays, biochemical assays, ex vivo and in silico. Cellular assays market is estimated to grow at a double digit CAGR during the forecast period (2013-2018). Cellular assays can predict the biological properties of potential drug compounds. These assays can also detect and measure cell viability, functionality and growth. Under the applications, the market is segmented into systemic toxicity, dermal toxicity, ocular toxicity, endocrine disruption (reproductive & developmental toxicity) and others. Systemic toxicity testing was the largest segment in 2013. The increasing focus on detection of toxicity in earlier stages of development is leading to persistent requirement for human cell-based in vitro models for cardiotoxicity and liver toxicity testing which are the major reasons for drug attrition. Europe commanded the largest share of the global market in 2013. This is attributed to the support provided by the European government for anti-animal testing laws. The government has further put ban on the production and sale of all animal tested cosmetics across the continent. The market will be driven by increasing acceptance of in-vitro toxicology testing methods as alternatives to in vivo toxicology testing. The new technologies in the in vitro testing market help in investigating the adverse effects of environmental agents in a more mechanistic and time saving manner. Organizations such as REACH foresee that more results of in vitro and in silico methods will be included in risk assessment which will promote the use of in vitro methods for toxicology testing. Scope Industry - Diagnostic - Pharmaceutical - Cosmetics - Chemical Technology - Cell Culture - HTS - Omics Applications - Systemic - Dermal - Ocular Method - Cellular Assay - Ex vivo - In Silico Key Topics Covered: - Introduction - Executive Summary - Premium Insights - Market Overview - By Industry - By Technology - By Application - By Method - Geographic Analysis - Competitive Landscape - Company Profiles - Agilent Technologies, Inc. - Alere, Inc. - Bio-Rad Laboratories, Inc. - Bioreliance, Inc. - Catalent - Charles River Laboratories International, Inc. - Covance, Inc. - Cyprotex - Eurofins Scientific - GE Healthcare - Life Technologies Corporation - Quest Diagnostics Visit http://www.researchandmarkets.com/research/59cs9d/invitro
Agilent Technologies Taps Paul Clark and James Cullen to Join Keysight Technologies Board of Directors
Business Wire - Tue Apr 08, 3:05PM CDT
Agilent Technologies Inc. (NYSE: A) today announced that it plans to appoint Paul N. Clark and James G. Cullen to the board of directors of Keysight Technologies, Inc. Clark is expected to become Keysight's chairman of the board.
TRADE NEWS: Agilent Technologies and FIME Announce Availability of Mobile Payment Test Systems Based on EMV Contactless Level 1 Specifications
Business Wire - Tue Apr 08, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) and FIME, a secure-chip consulting and testing provider, today announced the availability of test systems based on the EMV(R) Contactless Level 1 Specification for mobile payments.
Global Proteomics Market (Technology, Instruments, Reagents & Services) - Global Forecast to 2018
M2 - Tue Apr 08, 6:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2hnkrt/proteomics_market) has announced the addition of the "Proteomics Market by Technology, Instruments, Reagents & Services - Global Forecast to 2018" report to their offering. The global market was valued at an estimated $10,223.3 million in 2013. The growth of this market is mainly fuelled by the increasing need for personalized medicine, growth in pharmaceutical and biotechnology research and development (R&D) expenditure, technological advancements, and availability of government and private funding for proteomics projects.The overall market is further divided into four major geographies, namely, North America, Europe, Asia, and the Rest of the World (RoW). These regions are further analyzed at the country level. This report discusses the key market drivers, restraints, and opportunities in the global proteomics market and its sub-markets. Based on reagents type, the market is segmented into protein microarray, spectroscopy, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation kits. Furthermore, the services market is sub-divided into analytical laboratory services, and data analysis and maintenance. Analytical laboratory services are further segmented into three types, namely, protein identification, protein separation, and protein sequencing. Data analysis and maintenance is further divided into bioinformatics databases and bioinformatics tools. North America accounted for the largest share of the global market in 2013, followed by Europe, Asia-Pacific, and the Rest of the World. Developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to the Asian market. The growth in the Asian market is attributed to the shift of focus of the proteomics research-related industries towards Asia and the increase in both public and private funding to boost proteomic research in the region. Scope of the Report Proteomics Instrumentation Technologies - Protein Microarray - - Biochips - - Microarray instruments - Spectroscopy - - Mass spectrometry - - NMR spectrometry - - Circular dichroism (CD) spectroscopy - X-ray Crystallography - Chromatography - - HPLC Systems - - Affinity chromatography - - Ion chromatography - Supercritical Fluid Chromatography - Electrophoresis - - Gel electrophoresis - - Capillary electrophoresis - Surface Plasmon Resonance System (SPR System) - Protein Fractionation System Proteomics Reagents - Microarray - Spectroscopy - X-ray Crystallography - Chromatography - Electrophoresis - Immunoassay - Microsphere - Protein Fractionation Kits Proteomics Services - Analytical Laboratory Services - Protein Identification - Protein Separation - Protein Sequencing - Data Analysis and Maintenance - Bioinformatics Databases - Bioinformatics Tools - Global Proteomics Market, by Application - Drug Discovery - Diagnosis Key Topics Covered: - Introduction - Executive Summary - Premium Insights - Market Overview - Proteomics Instrumentation Technology - Proteomics Reagents Market - Proteomics Services Market - Proteomics Applications Market - Geographic Analysis - Competitive Landscape - Company Profiles - Thermo Fisher Scientific Inc. - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Luminex Corporation - Danaher Corporation - Ge Healthcare - Waters Corporation - Affymetrix Inc. - Perkinelmer, Inc. - Sigma-Aldrich Corp Visit http://www.researchandmarkets.com/research/2h...ics_market
Even With A Change At The Top, Danaher Corporation Will Roll On
Stephen D., Simpson,, The Motley Fool - Motley Fool - Thu Apr 17, 5:30PM CDT
Multi-industry conglomerate Danaher definitely buried the lede this quarter, as news of the unexpected retirement of well-liked CEO H. Lawrence Culp next year overshadowed an otherwise "OK ... but not great" quarter. Losing a good CEO is also a...
Danaher CEO Change, Guidance Underwhelm Investors
at Investor's Business Daily - Thu Apr 17, 11:31AM CDT
Scientific instrument maker Danaher (DHR) was down 1.5% in heavy volume in morning trading on the stock market today after it announced a new CEO and guided Q2 a bit below consensus. Late Wednesday, Danaher released Q1 earnings and announced that CEO...
Agilent Technologies Thought Leader Award Supports Dr. Joshua Rabinowitz's Research at Princeton University
Business Wire - Thu Apr 17, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) today announced that Joshua Rabinowitz, M.D., Ph.D., professor at Princeton University's Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics, has received an Agilent Thought Leader Award to support his work on quantitative analysis of cellular metabolism.
TRADE NEWS: Agilent Technologies Announces Certification of HDMI 2.0 Test Solution for HDMI 2.0 Compliance Test, With Widest Coverage of Test Items
Business Wire - Thu Apr 17, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) today announced that the Agilent HDMI 2.0 test solution has been certified by the HDMI Forum as an official compliance test tool. The solution has the widest coverage for HDMI Physical layer compliance test. Certification was achieved with the collaborative framework of Panasonic; the solution will be used at the Panasonic Authorized Test Center, in Osaka, Japan.
Global Liquid Chromatography Systems Market 2014-2018 with Agilent, GE, Shimadzu, Thermo Fisher Scientific & Waters Dominating
M2 - Thu Apr 17, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3svgnk/global_liquid) has announced the addition of the "Global Liquid Chromatography Systems Market 2014-2018" report to their offering. The Global Liquid Chromatography Systems market to grow at a CAGR of 5.55 percent over the period 2013-2018. One of the major trends witnessed in the market is the increased outsourcing of drug manufacturing to the APAC region. Many global pharmaceutical companies are facing challenges such as patent expirations and pricing pressures. As a result, these companies are on the lookout for cost-containment measures. For instance, drug manufacturing in the APAC countries is less expensive than in western countries. Therefore, western nations are increasingly outsourcing all the stages of the manufacturing process, including the purification of biopharmaceutical and other biochemical entities, to the CROs and CMOs located in the APAC region to achieve cost-efficiency. As a result, the APAC region is emerging as the fastest growing market and many multinational companies and local companies have set up their operations in this region to provide automated liquid chromatography systems to CROs and CMOs. Therefore, the continuous outsourcing of pharmaceutical production to the APAC region is expected to drive the growth of the Global Liquid Chromatography Systems market. According to the report, one of the major drivers in this market is the increasing automation of liquid chromatography systems. The usage of automated liquid chromatography instruments with auto-samplers to process large number of samples and the usage of analyzers with customized system settings have gained popularity recently. Further, the report states that one of the major challenges in this market is the requirement for high purification standards. To maintain the efficiency of liquid chromatography instruments, vendors are forced to build standards to deliver the highest quality systems. Moreover, the complex nature of biochemical entities poses a challenge for vendors to develop and maintain the instrument standards for purification. Liquid chromatography systems include: - HPLC - UHPLC - Others types of liquid chromatography systems Key Vendors - Agilent Technologies Inc. - GE Healthcare - Shimadzu Corp. - Thermo Fisher Scientific Inc. - Waters Corp. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product Type - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/3s...bal_liquid
TRADE NEWS: Agilent Technologies Announces Availability of Reference Solutions That Speed Test-System Development
Business Wire - Wed Apr 16, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) today announced the availability of Reference Solutions, a combination of hardware, software and measurement expertise that delivers the essential components of electronic test systems.
Research and Markets: Global Companion Diagnostics Market 2014-2018 with Abbott Laboratories, Agilent Technologies, bioMrieux SA, Qiagen N.V. & Roche Holding Dominating
Business Wire - Wed Apr 16, 6:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/84cgmr/global_companion) has announced the addition of the "Global Companion Diagnostics Market 2014-2018" report to their offering.
Global Companion Diagnostics Market 2014-2018 with Abbott Laboratories, Agilent Technologies, bioMerieux SA, Qiagen N.V. & Roche Holding Dominating
M2 - Wed Apr 16, 5:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3lb2g2/global_companion) has announced the addition of the "Global Companion Diagnostics Market 2014-2018" report to their offering. The Global Companion Diagnostics market will grow at a CAGR of 18.59 percent over the period 2013-2018. One of the major trends being witnessed in the market is the increase in growth strategies among vendors. Many diagnostic companies are adopting various strategies such as licensing agreements, product launches, collaborations, acquisitions, capital investment, and government support to develop companion diagnostic theranostic tests and targeted therapeutics and to strengthen their diagnostics product portfolio. Thus, many such activities are expected to boost the development of new diagnostic devices, thereby bolstering the growth of the Global Companion Diagnostics market during the forecast period. According to the report, the increased focus on cost cutting in the drug discovery and development process is one of the major drivers. The growth of genomics and proteomics has enabled the understanding of different expression stages associated with a specific disease among the human population. This has enabled many companies to develop highly specific drugs known as targeted therapeutics. It has also allowed better management of the drug development process, resulting in effective cost management. The paradigm shift in the focus to develop targeted therapeutics has enabled the development of companion diagnostic tests to monitor and administer patients with ease. Further, the report states that one of the major challenges in this market is the high cost involved in the development of companion diagnostics. The cost of developing companion diagnostics is high and adds to the overall cost of the targeted therapeutics and diagnostic tests. This report covers the present scenario and the growth prospects of the Global Companion Diagnostics market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of companion diagnostic tests and associated kits provided by the vendors. It also presents the vendor landscape and a corresponding detailed analysis of key five vendors in the Global Companion Diagnostics market. The market is highly fragmented, with the presence of many small and large vendors. It includes vendors that operate across the globe and have a substantial presence in North America and the European Union. In addition, the report discusses the major drivers that influence the growth of the Global Companion Diagnostics market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market. Key Vendors - Abbott Laboratories - Agilent Technologies Inc. - bioM?rieux SA - Qiagen N.V. - Roche Holding AG Other Prominent Vendors - 20/20 Genesystems Inc. - A & G Pharmaceutical Inc. - AccuTheranostics Inc. - Alacris Theranostics GmbH - AutoGenomics Inc. - Biogenex Laboratories Inc. - Leica Biosystems GmbH - Life Technologies Inc. - Luminex Corp. - pHLOGISTIX LLC - Spartan Bioscience Inc. - TheraDiag S.A. - Theranostics Health Inc. - Ventana Medical Systems Inc. Key Market Drivers/Trends/Challenges - Increasing Focus on Reducing the Cost of Drug Discovery and Development. - High Cost Associated with the Development of Companion Diagnostics. - Increase in Growth Strategies among Vendors Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/3l..._companion
Coverage of Health Care Sector Stocks -- Research on Agilent Technologies, Thermo Fisher Scientific, Nordion, and BG Medicine
PR Newswire - Tue Apr 15, 10:08AM CDT
On Monday, April 14, 2014, the NASDAQ Composite ended at 4,022.69, up 0.57%, the Dow Jones Industrial Average advanced 0.91% to 16,173.24, and the S&P 500 closed at 1,830.61, up 0.82%. The gains were broad based as all the 10 sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has declined 3.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), Nordion Inc. (NYSE: NDZ) and BG Medicine Inc. (NASDAQ: BGMD). Free technical research on A, TMO, NDZ and BGMD can be downloaded upon signing up at:
TRADE NEWS: Agilent Technologies Offers First User-Extensible Recorder Application for Real-Time Spectrum Analyzers
Business Wire - Tue Apr 15, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) today announced the availability of the option RTR, the industry's first real-time spectrum recorder and analyzer application example for real-time spectrum analyzers (RTSAs).
Xilinx's DDR4 Memory Solution for UltraScale Devices Completes Agilent N6462A Compliance Test Running at 2400 Mb/s
PR Newswire - Mon Apr 14, 6:00AM CDT
Xilinx, Inc. (NASDAQ: XLNX) and Agilent Technologies Inc. (NYSE:A) today announced Xilinx's DDR4 memory solution for UltraScale(TM) devices has completed the Agilent N6462A compliance test running at 2400 Mb/s. As defined by the JEDEC JESD79-4 DDR4 DRAM specification, the Agilent N6462A DDR4 compliance test enables early adopters of DDR4 technology to make critical electrical and timing analysis for characterization and margin testing purposes. The DDR4 memory interface in the Xilinx® UltraScale(TM) All Programmable FPGAs provides more than 1 Tb/s of memory bandwidth to handle the massive data flow, fast processing, and enormous memory requirements of leading-edge, next-generation system designs in key applications such as video imaging and processing, traffic management, and high-performance computing.
Global Molecular Spectroscopy (NMR, UV-Visible, IR, NIR, Raman) Market 2014-2018
M2 - Fri Apr 11, 9:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5g3ztn/molecular) has announced the addition of the "Global Molecular Spectroscopy (NMR, UV-Visible, IR, NIR, Raman) Market 2014-2018" report to their offering. Owing to the diverse nature of molecular spectroscopy technologies, these technologies cover a wide area of applications. The wide application of NMR spectroscopy, improvements in Raman technologies, and miniaturization of molecular spectroscopy instruments are the factors that are contributing to the growth of the market. The demand for molecular spectroscopy systems is growing, owing to the increasing requirements in the life sciences and pharmaceutical industries as wells as the substantial demand from the chemical and petrochemical industries. Moreover, the growing market for terahertz technology has resulted in the rapid growth of the market. The key factors propelling the growth of this market are increased investments, funding, and grants by government bodies worldwide; ongoing new product launches; technological advancements; increase in the number of conferences, which helps to create awareness about molecular spectroscopy techniques; growing concerns over food and drug safety; and increasing use of molecular spectroscopy techniques in the fields of proteomics, biomarkers, and metabolomics. This report broadly categorizes the global market into different technologies and applications. Based on products, the market comprises NMR Spectroscopy, Ultraviolet-Visible Spectroscopy (UV-Vis), Infrared Spectroscopy (IR), Near Infrared (NIR) Spectroscopy, Color Measurement Spectroscopy, Raman Spectroscopy, and others. The NMR Spectroscopy segment includes Continuous Wave NMR spectroscopy, Fourier Transform NMR spectroscopy, Solid-State NMR spectroscopy, and others. The Ultraviolet-Visible Spectroscopy (UV-Vis) segment comprises Single-beam UV-vis spectroscopy, Dual-beam UV-vis spectroscopy, Array-based UV-vis spectroscopy, handheld UV-vis spectroscopy, and others. The Infrared Spectroscopy (IR) market is further segment into market by spectrum and market by technology. The IR market by spectrum includes short-wave Infrared spectroscopy, mid-wave Infrared spectroscopy, and far-wave Infrared spectroscopy. The IR market by technology includes markets for benchtop, hyphenated, microscopy, portable, and terahertz spectroscopy. The Raman spectroscopy market is segmented by sampling technique and by technology. NMR spectroscopy accounted for the largest share of the overall molecular spectroscopymetry market, by technology, followed by UV-VIS spectroscopy. However, the Raman spectroscopy segment is expected to grow at the highest CAGR from 2013 to 2018. This high growth can be attributed to its technological advancements, and growing adoption in the pharmaceutical industry. Based on applications, the market is segmented into pharmaceuticals, biotechnology & biopharmaceuticals, food & beverage testing, environmental testing, academic research institutes, and others. Based on geography, the market is divided into North America, Europe, Asia, and the Rest of World (RoW). North America is the largest market for molecular spectroscopy, followed by Europe and Asia. However, the Asian market is slated to grow at the highest rate over the next five years. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 By Technology 5 By Application 6 By Geography 7 Competitive Landscape 8 Company Profiles - Agilent Technologies, Inc. - Bruker - Danaher Corporation - Foss - Jasco, Inc. - Jeol Ltd. - Perkinelmer, Inc. - Shimadzu Corporation - The Abb Group - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/5g3ztn/molecular
5 Stocks to Sell Before It's Too Late
at The Street - Fri Apr 11, 7:38AM CDT
It's time to unload these toxic stocks from your portfolio.
Global High Throughput Screening (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics) Market 2014-2018
M2 - Fri Apr 11, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnx4xn/high_throughput) has announced the addition of the "High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018" report to their offering. The global HTS market was valued at $13,736 million in 2013 and is expected to reach $19,627 million by 2018, at a CAGR of 7.4% In recent years, the high throughput screening (HTS) market has witnessed a large number of technological advancements, which has resulted in an increase in the rate of adoption of HTS in laboratories. . The HTS market is broadly classified into five segments, namely, technologies, products, applications, end users, and geography. The technology market is sub-divided into ultra high throughput screening, cell-based assays, lab-on-a chip, label-free technology, and bioinformatics. The cell-based assays segment dominated the HTS market in 2013, followed by the lab-on-a-chip segment. The HTS products market is broadly categorized into instruments, consumables/reagents, and software and services. The consumables/reagents segment dominated this market in 2013, with a market share of around 57%. The applications market is segmented into target identification, primary screening, toxicology, stem cell biology, and others. Target identification dominated the HTS applications market in 2013, followed by the primary screening market. The HTS market by end user is broadly categorized into pharmaceutical companies, biotechnology companies, academic and government institutes, contract research organizations (CROs), and others. The pharmaceuticals segment dominated the market in 2013, with a market share of around 48%. The major factors driving the growth of the HTS market are technological innovations, open innovation models adopted by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in HTS technology by organizations. Moreover, the presence of a large untapped market in emerging countries and growth in outsourcing of drug discovery services especially in China and India are the various factors that are expected to provide growth opportunities for players in this market. However, the capital intensive nature of HTS and difficulties in assay development for novel target classes are the factors curbing the growth of this market. Company Profiles - Agilent Technologies, Inc. - Aurora Biomed - Axxam Spa - Beckman Coulter, Inc. (A Subsidiary Of Danaher) - Bio-Rad Laboratories - Biofocus Dpi Ltd. - Intellicyt Corporation - Luminex Corporation - Perkinelmer, Inc. - Sigma Aldrich Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. Scope of the Report Technology - Cell-Based Assay - Ultra high throughput screening (uHTS)Lab-on-a-chip - Label Free Technology - Bioinformatics Product - Instruments - Consumables/Reagents - Software and Services Application - Target Identification - Primary Screening - Toxicology - Stem Cell Biology - Others End User - Pharmaceutical - Biotechnology - Academic & Government Organizations - Contract Research Organizations - Others For more information visit http://www.researchandmarkets.com/research/wn...throughput
African Electronic Test Equipment Market Report 2014 - Telecoms & Education Present Significant Opportunities in the Next 5-7 Years
M2 - Wed Apr 09, 10:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j8npbx/african) has announced the addition of the "African Electronic Test Equipment Market" report to their offering. Africa is an emerging market for vendors of electronic test equipment. Its telecommunications and education sectors present significant opportunities in the next 5 to 7 years. This research service analyzes the market for the major types of electronic test equipment, including oscilloscopes, spectrum analyzers, network analyzers, signal generators, multimeters, power meters, electronic counters, logic analyzers, and arbitrary waveform generators. Featuring revenue forecast for the total market as well as each product segment, it analyzes the market from an end-user and geographic perspective. A detailed market share analysis by revenue of the leading participants is also supplied at the regional level. Key Topics Covered: - Introduction - Executive Summary - Market Overview - Total Market - CEO 360 degree Perspective - Oscilloscopes Segment Breakdown - Spectrum Analyzers Segment Breakdown - Network Analyzers Segment Breakdown - Multimeters Segment Breakdown - Signal Generators Segment Breakdown - Power Meters Segment Breakdown - Electronic Counters Segment Breakdown - Logic Analyzers Segment Breakdown - AWG Segment Breakdown - North Africa Breakdown - Sub-Saharan Africa Breakdown - The Last Word - Appendix Companies Mentioned - Aeroflex - Agilent Technologies - Anritsu - Boonton Electronics - Comtest - Concilium Technologies - Extech - Fluke - Good Will Instruments - Hameg - LeCroy - Major Tech - RIGOL - Rohde & Schwarz - Tektronix - Yokogawa For more information visit http://www.researchandmarkets.com/research/j8npbx/african
Agilent names Paul Clark and James Cullen as directors on Keysight Technologies' board
M2 - Wed Apr 09, 9:42AM CDT
Agilent Technologies Inc (NYSE:A), a measurement and technology company, revealed on Tuesday that it will appoint Paul N Clark and James G Cullen to Keysight Technologies Inc's board of directors and Clark will become the chairman of the board.
Global In-Vitro Toxicology/Toxicity Testing (Cell Culture, HTS, Omics) Market 2014-2018
M2 - Wed Apr 09, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/59cs9d/invitro) has announced the addition of the "In-Vitro Toxicology/ Toxicity Testing Market by Industry, Technology, Applications & Method - Global Forecast to 2018" report to their offering. The global market of in-vitro toxicology testing is subdivided into industry, technology, method, application and geography. On the basis of industry, the market is further segmented into diagnostics, pharmaceuticals, chemicals, cosmetics, and food. Diagnostics is further categorized into sample and type. The largest market share was captured by the pharmaceutical industry, whereas cosmetics industry was the fastest growing industry with a double digit CAGR. The prime factor contributing to the growth of pharmaceutical industry has been the attention towards the detection of toxicity during earlier stages of development. On the basis of technology, the global market of in vitro toxicology testing is divided into cell culture, high throughput screening, cellular imaging, and omics technologies. Cell culture technology will witness the maximum growth rate in the coming years. The methods considered for the study are cellular assays, biochemical assays, ex vivo and in silico. Cellular assays market is estimated to grow at a double digit CAGR during the forecast period (2013-2018). Cellular assays can predict the biological properties of potential drug compounds. These assays can also detect and measure cell viability, functionality and growth. Under the applications, the market is segmented into systemic toxicity, dermal toxicity, ocular toxicity, endocrine disruption (reproductive & developmental toxicity) and others. Systemic toxicity testing was the largest segment in 2013. The increasing focus on detection of toxicity in earlier stages of development is leading to persistent requirement for human cell-based in vitro models for cardiotoxicity and liver toxicity testing which are the major reasons for drug attrition. Europe commanded the largest share of the global market in 2013. This is attributed to the support provided by the European government for anti-animal testing laws. The government has further put ban on the production and sale of all animal tested cosmetics across the continent. The market will be driven by increasing acceptance of in-vitro toxicology testing methods as alternatives to in vivo toxicology testing. The new technologies in the in vitro testing market help in investigating the adverse effects of environmental agents in a more mechanistic and time saving manner. Organizations such as REACH foresee that more results of in vitro and in silico methods will be included in risk assessment which will promote the use of in vitro methods for toxicology testing. Scope Industry - Diagnostic - Pharmaceutical - Cosmetics - Chemical Technology - Cell Culture - HTS - Omics Applications - Systemic - Dermal - Ocular Method - Cellular Assay - Ex vivo - In Silico Key Topics Covered: - Introduction - Executive Summary - Premium Insights - Market Overview - By Industry - By Technology - By Application - By Method - Geographic Analysis - Competitive Landscape - Company Profiles - Agilent Technologies, Inc. - Alere, Inc. - Bio-Rad Laboratories, Inc. - Bioreliance, Inc. - Catalent - Charles River Laboratories International, Inc. - Covance, Inc. - Cyprotex - Eurofins Scientific - GE Healthcare - Life Technologies Corporation - Quest Diagnostics Visit http://www.researchandmarkets.com/research/59cs9d/invitro
Agilent Technologies Taps Paul Clark and James Cullen to Join Keysight Technologies Board of Directors
Business Wire - Tue Apr 08, 3:05PM CDT
Agilent Technologies Inc. (NYSE: A) today announced that it plans to appoint Paul N. Clark and James G. Cullen to the board of directors of Keysight Technologies, Inc. Clark is expected to become Keysight's chairman of the board.
TRADE NEWS: Agilent Technologies and FIME Announce Availability of Mobile Payment Test Systems Based on EMV Contactless Level 1 Specifications
Business Wire - Tue Apr 08, 10:00AM CDT
Agilent Technologies Inc. (NYSE: A) and FIME, a secure-chip consulting and testing provider, today announced the availability of test systems based on the EMV(R) Contactless Level 1 Specification for mobile payments.
Global Proteomics Market (Technology, Instruments, Reagents & Services) - Global Forecast to 2018
M2 - Tue Apr 08, 6:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2hnkrt/proteomics_market) has announced the addition of the "Proteomics Market by Technology, Instruments, Reagents & Services - Global Forecast to 2018" report to their offering. The global market was valued at an estimated $10,223.3 million in 2013. The growth of this market is mainly fuelled by the increasing need for personalized medicine, growth in pharmaceutical and biotechnology research and development (R&D) expenditure, technological advancements, and availability of government and private funding for proteomics projects.The overall market is further divided into four major geographies, namely, North America, Europe, Asia, and the Rest of the World (RoW). These regions are further analyzed at the country level. This report discusses the key market drivers, restraints, and opportunities in the global proteomics market and its sub-markets. Based on reagents type, the market is segmented into protein microarray, spectroscopy, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation kits. Furthermore, the services market is sub-divided into analytical laboratory services, and data analysis and maintenance. Analytical laboratory services are further segmented into three types, namely, protein identification, protein separation, and protein sequencing. Data analysis and maintenance is further divided into bioinformatics databases and bioinformatics tools. North America accounted for the largest share of the global market in 2013, followed by Europe, Asia-Pacific, and the Rest of the World. Developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to the Asian market. The growth in the Asian market is attributed to the shift of focus of the proteomics research-related industries towards Asia and the increase in both public and private funding to boost proteomic research in the region. Scope of the Report Proteomics Instrumentation Technologies - Protein Microarray - - Biochips - - Microarray instruments - Spectroscopy - - Mass spectrometry - - NMR spectrometry - - Circular dichroism (CD) spectroscopy - X-ray Crystallography - Chromatography - - HPLC Systems - - Affinity chromatography - - Ion chromatography - Supercritical Fluid Chromatography - Electrophoresis - - Gel electrophoresis - - Capillary electrophoresis - Surface Plasmon Resonance System (SPR System) - Protein Fractionation System Proteomics Reagents - Microarray - Spectroscopy - X-ray Crystallography - Chromatography - Electrophoresis - Immunoassay - Microsphere - Protein Fractionation Kits Proteomics Services - Analytical Laboratory Services - Protein Identification - Protein Separation - Protein Sequencing - Data Analysis and Maintenance - Bioinformatics Databases - Bioinformatics Tools - Global Proteomics Market, by Application - Drug Discovery - Diagnosis Key Topics Covered: - Introduction - Executive Summary - Premium Insights - Market Overview - Proteomics Instrumentation Technology - Proteomics Reagents Market - Proteomics Services Market - Proteomics Applications Market - Geographic Analysis - Competitive Landscape - Company Profiles - Thermo Fisher Scientific Inc. - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Luminex Corporation - Danaher Corporation - Ge Healthcare - Waters Corporation - Affymetrix Inc. - Perkinelmer, Inc. - Sigma-Aldrich Corp Visit http://www.researchandmarkets.com/research/2h...ics_market
(0)
(0)
